Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Peloton Stock Dipped Today: Here's What We Know

Peloton Interactive Inc (NASDAQ: PTON) shares are trading lower Wednesday. What's going on?

Benzinga

Tigress Financial Lists Reasons Behind Bullishness On Amazon

Tigress Financial analyst Ivan Feinseth reiterated Amazon.com Inc (NASDAQ:AMZN) with a Buy and maintained a $232 price target. He saw ongoing momentum in Prime Membership, increasing traction with third-party sellers, strength in AWS, and growth and share price gains. He believed that growth in Prime membership, ongoing momentum in AWS, and increasing advertising revenue growth…

Benzinga

Here's Why Volkswagen CEO Thinks Tesla Is Weakening Itself Right Now

The battle for dominance in the electric vehicle market is heating up and Volkswagen AG (OTC: VWAGY) believes it can pass Tesla Inc (NASDAQ: TSLA) in the coming years.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

This Analyst Believes Seagen Is Evaluating Strategic Alternatives

Raymond James initiated coverage on Seagen Inc (NASDAQ:SGEN) at Outperform with a $220 target price. Citing the recent departure of the long-time Seagen CEO, Raymond James thinks that the Board of Directors is likely evaluating strategic alternatives for the company. The relationship with Merck & Company, Inc. (NYSE:MRK) has been long-standing. With Keytruda losing its patent…

Benzinga

Analysts Still Believe Verrica's Ycanth Is Approvable Despite FDA Response Letter

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) held a Type A meeting with the FDA regarding the path forward for the resubmission and potential approval of Ycanth (VP-102) for molluscum contagiosum. HC Wainwright says VP-102 was approvable, and at the time of the Complete Response Letter (CRL), Verrica had already engaged a potential alternate solution supplier. It reiterates…

Benzinga

What SVB Says On Axsome's Strategy Review On Sunosi For Sleeping Disorder

Axsome Therapeutics Inc (NASDAQ: AXSM) held an investor event to review its strategy with Sunosi, which is indicated for excessive daytime sleepiness (EDS) in narcolepsy and obstructive sleep apnea (OSA). SVB Leerink says its view on Sunosi has not changed.

Benzinga

Rosenblatt Points Out How Intel's Price War Could Prove Costly For AMD

Rosenblatt analyst Hans Mosesmann shared salient articles in the last week specific to AI, Bandwidth, and Compute that are important and merely interesting regarding key secular themes.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

KeyBanc Endorses Pinterest, Disney's CEO Transition - Key Takeaways

KeyBanc hailed the CEO successions in two significant companies citing different reasons.

Benzinga

Ryan Cohen Throws Shade Following Mark Tritton's Bed Bath & Beyond Dismissal: 'I'm Sick Of Seeing Failed Executives'

Mark Tritton is no longer CEO of Bed Bath & Beyond Inc (NASDAQ: BBBY) — and Ryan Cohen might be one reason why.

Benzinga

1stdibs Divests Design Manager To Performant Capital

1stdibs.Com, Inc. (NASDAQ:DIBS) has sold Design Manager to the Chicago-based private equity firm Performant Capital for an undisclosed sum. Design Manager is a project management and accounting software company for the interior design industry. Design Manager offers software workflow solutions, and clients use the platform to manage design projects totaling $2 billion in billings…

Benzinga

Why Shares Of Allena Pharmaceuticals Are Skyrocketing Today

Shares of small-cap penny stock Allena Pharmaceuticals (NASDAQ: ALNA) shares are trading higher after the company announced it has terminated its previously announced at-the-market offering.

Benzinga

$100 Invested In Keurig Dr Pepper 10 Years Ago Would Be Worth This Much Today

Keurig Dr Pepper (NASDAQ:KDP) has outperformed the market over the past 10 years by 6.9% on an annualized basis producing an average annual return of 17.64%. Currently, Keurig Dr Pepper has a market capitalization of $50.93 billion.

Benzinga

Needham's Developer Checks For Wix.com Highlight Continued Funnel Weakness

Needham analyst Bernie McTernan reiterated a Buy rating and $85 price target on Wix.com Ltd (NASDAQ:WIX) following a round of web developer checks. He spoke with 22 developers in the WIX Marketplace to shed light on the broader funnel. They did not indicate any improvement. Failure of the funnel to return puts his 2H'22E and…

Benzinga

Dow Jumps 150 Points; Icosavax Shares Plunge

U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Here's What Rosenblatt Expects From Micron's Upcoming Quarterly Results

Micron Technology, Inc (NASDAQ: MU) reports May quarter earnings on June 30, after market close.

Benzinga

Why AMD And Nvidia Shares Are Dipping Today

Advanced Micro Devices, Inc. (NASDAQ: AMD) and NVIDIA Corporation (NASDAQ: NVDA) shares are trading lower after B of A Securities maintained bullish ratings on the stock but lowered its price targets.

Benzinga

Happy Tesla IPO Anniversary: Here's How Much Investing $1,000 In The Tesla IPO Is Worth Today

Electric vehicle leader Tesla Inc (NASDAQ: TSLA) went public on June 29, 2010. Investors who bought and held the IPO have been pleasantly rewarded since that time. Here’s a look at just how much investors could have made in the IPO.

Benzinga

4 Analysts Have This to Say About Addus HomeCare

Addus HomeCare (NASDAQ:ADUS) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Analyst Ratings for Vacasa

Vacasa (NASDAQ:VCSA) has observed the following analyst ratings within the last quarter:

Benzinga

What 6 Analyst Ratings Have To Say About GLOBALFOUNDRIES

Analysts have provided the following ratings for GLOBALFOUNDRIES (NASDAQ:GFS) within the last quarter:

Benzinga

What 4 Analyst Ratings Have To Say About Wynn Resorts

Analysts have provided the following ratings for Wynn Resorts (NASDAQ:WYNN) within the last quarter:

Benzinga

Here's How Much You Would Have Made Owning Illumina Stock In The Last 15 Years

Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 9.39% on an annualized basis producing an average annual return of 15.68%. Currently, Illumina has a market capitalization of $29.25 billion.

Benzinga

Kraft Heinz Inks Power Purchase Pact With Berkshire Hathaway Energy Business

Kraft Heinz Co (NASDAQ:KHC) has signed a virtual power purchase agreement with BHE Renewables, a Berkshire Hathaway Inc (NYSE: BRK-A) Energy business. Under the agreement, BHE will provide power from renewables to Kraft Heinz's operations within the U.S. The facilitation is part of Kraft Heinz's aim to procure most of its electricity from renewable sources…

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 15 Years

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 15 years by 12.24% on an annualized basis producing an average annual return of 18.51%. Currently, Intuitive Surgical has a market capitalization of $72.72 billion.

1 … 346 347 348 349

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.